SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1573 7403 "

Sökning: L773:1573 7403

  • Resultat 1-10 av 30
  • [1]23Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Tuy, Hoang, et al. (författare)
  • The Minimum Concave Cost Network Flow Problem with fixed numbers of sources and nonlinear arc costs
  • 1995
  • Ingår i: Journal of Global Optimization. - 0925-5001 .- 1573-2916. ; 6:2, s. 135-151
  • Tidskriftsartikel (refereegranskat)abstract
    • We prove that the Minimum Concave Cost Network Flow Problem with fixed numbers of sources and nonlinear arc costs can be solved by an algorithm requiring a number of elementary operations and a number of evaluations of the nonlinear cost functions which are both bounded by polynomials in r, n, m, where r is the number of nodes, n is the number of arcs and m the number of sinks in the network
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Casanueva, Felipe F., et al. (författare)
  • Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
  • 2017
  • Ingår i: Pituitary. - 1386-341X .- 1573-7403. ; 20, s. 489-498
  • Forskningsöversikt (refereegranskat)abstract
    • © 2017, The Author(s). Introduction: With the goal of generate uniform criteria among centers dealing with pituitary tumors and to enhance patient care, the Pituitary Society decided to generate criteria for developing Pituitary Tumors Centers of Excellence (PTCOE). Methods: To develop that task, a group of ten experts served as a Task Force and through two years of iterative work an initial draft was elaborated. This draft was discussed, modified and finally approved by the Board of Directors of the Pituitary Society. Such document was presented and debated at a specific session of the Congress of the Pituitary Society, Orlando 2017, and suggestions were incorporated. Finally the document was distributed to a large group of global experts that introduced further modifications with final endorsement. Results: After five years of iterative work a document with the ideal criteria for a PTCOE is presented. Conclusions: Acknowledging that very few centers in the world, if any, likely fulfill the requirements here presented, the document may be a tool to guide improvements of care delivery to patients with pituitary disorders. All these criteria must be accommodated to the regulations and organization of Health of a given country.
  •  
6.
  • Casar-Borota, Olivera, et al. (författare)
  • A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas
  • 2016
  • Ingår i: Pituitary. - 1386-341X .- 1573-7403. ; 19:4, s. 407-414
  • Tidskriftsartikel (refereegranskat)abstract
    • Inactivating mutations of isocitrate dehydrogenase (IDH) 1 and 2, mitochondrial enzymes participating in the Krebs tricarboxylic acid cycle play a role in the tumorigenesis of gliomas and also less frequently in acute myeloid leukemia and other malignancies. Inhibitors of mutant IDH1 and IDH2 may potentially be effective in the treatment of the IDH mutation driven tumors. Mutations in the succinate dehydrogenase, the other enzyme complex participating in the Krebs cycle and electron transfer of oxidative phosphorylation occur in the paragangliomas, gastrointestinal stromal tumors, and occasionally in the pituitary adenomas. We aimed to determine whether the IDH1(R132H) mutation, the most frequent IDH mutation in human malignancies, occurs in pituitary adenomas. We performed immunohistochemical analysis by using a monoclonal anti-IDH1(R132H) antibody on the tissue microarrays containing specimens from the pituitary adenomas of different hormonal types from 246 patients. In positive samples, the status of the IDH1 gene was further examined by molecular genetic analyses. In all but one patient, there was no expression of mutated IDH1(R132H) protein in the tumor cells by immunohistochemistry. Only one patient with a recurring clinically non-functioning gonadotroph adenoma demonstrated IDH1(R132H)-immunostaining in both the primary tumor and the recurrence. However, no mutation in the IDH1 gene was detected using different molecular genetic analyses. IDH1(R132H) mutation occurs only exceptionally in pituitary adenomas and does not play a role in their pathogenesis. Patients with pituitary adenomas do not seem to be candidates for treatment with the inhibitors of mutant IDH1.
  •  
7.
  •  
8.
  • Erfurth, Eva Marie, et al. (författare)
  • Mortality and morbidity in adult craniopharyngioma.
  • 2012
  • Ingår i: Pituitary. - : Springer. - 1573-7403.
  • Tidskriftsartikel (refereegranskat)abstract
    • A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5-2.0 cases/million/year and approximately 60 % of CP are seen in adulthood. Craniopharyngiomas have the highest mortality of all pituitary tumors. Typical initial manifestations at diagnosis in adults are visual disturbances, hypopituitarism and symptoms of elevated intracranial pressure. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health, and reduction in quality of life and cognitive function. Therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. The standardised overall mortality rate varies 2.88-9.28 in cohort studies. Patients with CP have a 3-19 fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk.
  •  
9.
  • Erfurth, Eva Marie, et al. (författare)
  • Pituitary disease mortality: is it fiction?
  • 2013
  • Ingår i: Pituitary. - : Springer. - 1573-7403. ; 16:3, s. 402-412
  • Tidskriftsartikel (refereegranskat)abstract
    • During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma.
  •  
10.
  • Esposito, Daniela, et al. (författare)
  • Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management.
  • 2019
  • Ingår i: Pituitary. - 1573-7403. ; 22:4, s. 422-434
  • Forskningsöversikt (refereegranskat)abstract
    • Non-functioning pituitary adenomas (NFPAs) are associated with impaired well-being, increased comorbidities, and reduced long-term survival. Data on optimal management of NFPAs around surgical treatment are scarce, and postoperative treatment and follow-up strategies have not been evaluated in prospective trials. Here, we review the preoperative, perioperative, and early postoperative management of patients with NFPAs.We searched Medline and the Cochrane Library for articles published in English with the following items "Pituitary neoplasms AND Surgery" and "Surgery AND Hypopituitarism". Studies containing detailed analyses of the management of NFPAs in adult patients, including pituitary surgery, endocrine care, imaging, ophthalmologic assessment and long-term outcome were reviewed.Treatment options for NFPAs include active surveillance, surgical resection, and radiotherapy. Pituitary surgery is currently recommended as first-line treatment in patients with visual impairment due to adenomas compressing the optic nerves or chiasma. Radiotherapy is reserved for large tumor remnants or tumor recurrence following one or more surgical attempts. There is no consensus of optimal pre-, peri-, and postoperative management such as timing, frequency, and duration of endocrine, radiologic, and ophthalmologic assessments as well as management of smaller tumor remnants or tumor recurrence.In clinical practice, there is a great variation in the treatment and follow-up of patients with NFPAs. We have, based on available data, suggested an optimal management strategy for patients with NFPAs in relation to pituitary surgery. Prospective trials oriented at drawing up strategies for the management of NFPAs are needed.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 30
  • [1]23Nästa
Typ av publikation
tidskriftsartikel (26)
forskningsöversikt (4)
Typ av innehåll
refereegranskat (27)
övrigt vetenskapligt (2)
populärvet., debatt m.m. (1)
Författare/redaktör
Johannsson, Gudmundu ... (7)
Erfurth, Eva Marie (5)
Stickley, Andrew (4)
Casar Borota, Oliver ... (4)
Koyanagi, A (2)
Koyanagi, Ai (2)
visa fler...
Nyström, Helena Fili ... (2)
Koltowska-Häggström, ... (2)
Ragnarsson, Oskar, 1 ... (2)
Bensing, Sophie (2)
Strasburger, Christi ... (2)
Skoglund, Thomas, 19 ... (2)
Haro, J. M. (2)
Papakokkinou, Eleni (2)
Bruno, G. (1)
Sundström, Magnus (1)
Pontén, Fredrik (1)
Engström, Britt Edén (1)
Björk, Thomas (1)
Feldt-Rasmussen, Ull ... (1)
Luger, Anton (1)
Esposito, Daniela (1)
Hokfelt, Tomas (1)
Lagerstrand, Kerstin ... (1)
Casanueva, Felipe F. (1)
Olsson, Tommy (1)
Kämpe, Olle (1)
Värbrand, Peter (1)
Jonsson, Björn (1)
Wahlberg, J. (1)
Hall, K (1)
Nystrom, T. (1)
Schwarcz, E. (1)
Smith, Roger (1)
Saeger, Wolfgang (1)
Falhammar, H (1)
Siesjö, Peter (1)
Migdalas, Athanasios (1)
Janson, Eva Tiensuu (1)
Burman, P. (1)
Erfurth, E. M. (1)
Bidlingmaier, Martin (1)
Biller, Beverly (1)
Burman, Pia (1)
Hoffman, Andrew R (1)
Johannsson, Gudmundu ... (1)
Biller, BMK (1)
Wiebe, Thomas (1)
Ezzat, Shereen (1)
Petersson, Maria (1)
visa färre...
Lärosäte
Uppsala universitet (10)
Göteborgs universitet (8)
Karolinska Institutet (6)
Lunds universitet (5)
Södertörns högskola (4)
Örebro universitet (2)
visa fler...
Umeå universitet (1)
Luleå tekniska universitet (1)
visa färre...
Språk
Engelska (30)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (18)
Samhällsvetenskap (4)
Naturvetenskap (1)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy